Apocynin improves outcome in experimental stroke with a narrow dose range

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Inflammation exacerbates ischemic stroke injury.
• NADPH oxidase (NOX) enzymes generate superoxide (O₂⁻), contributing to stroke pathology.
• Apocynin is a known NOX inhibitor investigated for stroke treatment.

Purpose of the Study:

• To investigate the dose-dependent effects of apocynin in a mouse model of ischemic stroke.
• To evaluate apocynin's impact on neurological function, infarct volume, cerebral hemorrhage, and mortality.
• To determine the role of superoxide generation in stroke and apocynin's effect on it.

Main Methods:

• Transient middle cerebral artery occlusion (tMCAO) for 2 hours followed by 22 hours of reperfusion in mice.
• Intravenous administration of varying doses of apocynin (2.5, 3.75, 5 mg/kg) before reperfusion.
• Assessment of neurological function, infarct volume, cerebral hemorrhage, and mortality.
• Hydroethidine fluorescence used to detect superoxide (O₂⁻) in brain tissue.

Main Results:

• The 2.5 mg/kg dose of apocynin significantly improved neurological function, reduced infarct volume, and decreased cerebral hemorrhage incidence.
• Higher doses (3.75 and 5 mg/kg) of apocynin increased cerebral hemorrhage.
• Apocynin at the protective dose reduced ischemia-induced superoxide generation in neurons and microglia/macrophages.
• A trend towards reduced mortality was observed with the lower dose of apocynin.

Conclusions:

• Apocynin demonstrates neuroprotective potential in experimental stroke, but its efficacy is dose-dependent.
• A narrow therapeutic window exists for apocynin, with higher doses proving detrimental.
• Superoxide generation in neurons and microglia is implicated in stroke injury, and apocynin can inhibit this process.